Skip to main content

Table 2 Chromatographic conditions for the experiments

From: Aerosol drug delivery to the lungs during nasal high flow therapy: an in vitro study

Compounds

Column

Mobile phase

Flow rate, mL/min

Injection volume, μL

Mannitol

Hi-Plex Ca2+, 300 × 7.7 mm, 8 μm (Agilent, Sydney, Australia)

Deionized water

0.6

50